Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices Medicare will pay for pharmaceuticals.

The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include ...

Currently, Medicare has to wait seven years after a traditional drug gets approved by the U.S. Food and Drug Administration ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

Medicare’s drug price negotiation program is progressing into its third round of selections, HHS announced last week. And as the Biden-era program moves full steam ahead, changes are in store ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

The Trump administration has issued new draft guidance for the third cycle of Medicare drug price negotiations. | The Trump ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

President Donald Trump signed an executive order Monday aiming to significantly reduce prescription drug prices in the United ...